Valuation : Clever Culture Systems Limited

Market Cap 41.46M 29.74M 25.57M 24.13M 21.98M 41.09M 2.84B 287M 111M 1.44B 112M 109M 4.58B P/E 2025
20x
P/E 2026 -21.1x
Enterprise Value 42.75M 30.66M 26.37M 24.88M 22.66M 42.36M 2.93B 296M 114M 1.49B 115M 113M 4.72B EV / Sales 2025
5.35x
EV / Sales 2026 11.1x
Free-Float
39.92%
Yield 2025 *
-
Yield 2026 -
1 week+46.15%
Current month+18.75%
1 month+26.67%
3 months-9.52%
6 months-26.92%
Current year-34.48%
1 week 0.02
Extreme 0.015
0.02
1 month 0.01
Extreme 0.013
0.02
Current year 0.01
Extreme 0.013
0.03
1 year 0.01
Extreme 0.013
0.04
3 years 0
Extreme 0.004
0.04
5 years 0
Extreme 0.004
0.16
10 years 0
Extreme 0.004
1.08
Manager TitleAgeSince
Chief Executive Officer - 2016-08-07
Director of Finance/CFO - 2017-08-24
Chief Tech/Sci/R&D Officer - 2017-01-31
Director TitleAgeSince
Director/Board Member - 2016-08-07
Chairman - 2023-06-30
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+46.15%-42.42%+11.76% 29.9M
-0.56%-8.08%-3.88%+10.58% 46.38B
-2.08%-3.57%+402.72%+533.09% 44.51B
+0.12%-5.27%+39.94%+20.50% 42.3B
-2.62%-5.76%+8.88%+77.44% 39.91B
-1.26%-3.37%+11.87%+40.55% 32.79B
+0.16%-3.65% - - 17.13B
-0.54%-1.72%+22.34%+115.10% 16.36B
-0.03%-3.46%+12.68%+30.90% 14.31B
-1.92%-6.94%+78.12%+36.68% 13.29B
Average -0.87%-0.30%+58.91%+97.40% 26.7B
Weighted average by Cap. -1.09%-4.53%+87.09%+129.34%

Financials

2025 2026
Net sales 5.46M 3.92M 3.37M 3.18M 2.9M 5.41M 374M 37.85M 14.57M 190M 14.71M 14.39M 603M 4.62M 3.31M 2.85M 2.69M 2.45M 4.58M 317M 32.01M 12.32M 161M 12.44M 12.17M 510M
Net income 1.68M 1.21M 1.04M 980K 893K 1.67M 115M 11.67M 4.49M 58.57M 4.54M 4.44M 186M -2.24M -1.6M -1.38M -1.3M -1.19M -2.22M -153M -15.51M -5.97M -77.83M -6.03M -5.9M -247M
Net Debt 950K 681K 586K 553K 504K 941K 65.14M 6.58M 2.53M 33.04M 2.56M 2.5M 105M 1.29M 922K 793K 748K 682K 1.27M 88.18M 8.91M 3.43M 44.72M 3.46M 3.39M 142M
Logo Clever Culture Systems Limited
Clever Culture Systems Limited is an Australia-based company, which provides intelligent automation solutions to microbiology laboratories. It has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates. The technology United States FDA-cleared artificial intelligence technology for automated culture plate reading. The product is being sold to microbiology laboratories in the pharmaceutical manufacturing sector for the reading of environmental monitoring culture plates and to clinical laboratories as an in vitro diagnostic for infectious diseases. Thermo Fisher Scientific, Inc is distributor of the APAS Independence to clinical customers in the United States and selected countries in Europe. It offers a range of APAS Independence Analysis Modules that are validated across multiple culture plate media and sample types.
Employees
19
Date Price Change Volume
26-09-10 A$0.0190 0.00% 535,702
26-09-09 A$0.0190 0.00% 696,670
26-09-08 A$0.0190 +5.56% 4,838,044
26-09-07 A$0.0180 +28.57% 2,385,025
26-09-04 A$0.0140 +7.69% 611,389
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!